Bottom line
Is IBBQ a good fund? The bottom line
IBBQ is an actively managed technology sector ETF from Invesco.
It charges 0.19% — about $19 a year on every $10,000 invested, cheaper than 96% of technology sector funds we track.
It returned −0.6% over one year (as of Dec 31, 2024, per its prospectus).
With $67.4 million in net assets and 261 holdings, its largest position is Invesco Private Prime Fund (14.2%) and the top 10 make up 56.6% of the portfolio.
What stands out
- Low cost: cheaper than 96% of technology sector peers
- Broadly diversified (261 holdings)
What to watch
- Concentrated: top 10 holdings are 56.6% of assets
Updated Nov 19, 2026
What IBBQ invests in
The Invesco Nasdaq Biotechnology ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index (the Underlying Index).
The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (Nasdaq or the Index Provider) compiles the Underlying Index, which is a modified market-capitalization weighted index that is designed to measure the performance of securities of companies listed on the Nasdaq Stock Market that are classified under the biotechnology subsector or pharmaceuticals subsector of the Industry Classification Benchmark (ICB). The Underlying Index may include securities of large-, mid- and small-capitalization companies. Securities in the Underlying Index are weighted by market capitalization. Security types generally eligible for inclusion in the Underlying Index include common stocks and American Depositary Receipts (ADRs) that represent securities of non-U.S.…
From the fund's prospectus (filed Dec 18, 2025).
IBBQ performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IBBQ | −0.6% | — | — |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Dec 31, 2024
What IBBQ costs
On a $10,000 investment, IBBQ's 0.19% expense ratio costs about $19 a year. The prospectus estimates $242 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.
IBBQ top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Invesco Private Prime Fund | 14.20% |
| 2 | Gilead Sciences, Inc. | 7.39% |
| 3 | Vertex Pharmaceuticals Inc. | 7.38% |
| 4 | Amgen Inc. | 7.10% |
| 5 | Invesco Private Government Fund | 5.48% |
| 6 | Regeneron Pharmaceuticals, Inc. | 5.08% |
| 7 | Alnylam Pharmaceuticals, Inc. | 3.19% |
| 8 | Revolution Medicines, Inc. | 2.48% |
| 9 | Biogen Inc. | 2.29% |
| 10 | Illumina, Inc. | 1.98% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 56.6% of the fund. See all top 25 holdings and asset mix →